Produkty 181225-33-2

CAS 181225-33-2 występuje w naszej ofercie pod nazwami: (E)-Ginsenoside F4, Ginsenoside F4 98%, Ginsenoside F4, 98.54%. Oferty producentów: TRC, Biosynth, Ambeed, MedChemExpress. Dostępne opakowania: 25mg, 10mg, 50mg, 5mg, 1 mg, 5 mg.

(E)-Ginsenoside F4
TRC, Biosynth
  • opakowanie: 25mg, 10mg, 50mg
  • Warianty: 4
Zobacz produkt
Ginsenoside F4 98%
Ambeed
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 4
od 798,69
Zobacz produkt
Ginsenoside F4, 98.54%
MedChemExpress
  • opakowanie: 1 mg, 5 mg
  • Warianty: 2
od 598,33
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol (CAS 181225-33-2) to związek chemiczny o wzorze sumarycznym C42H70O12 i masie molowej 767.0 g/mol. Nazwa systematyczna IUPAC: (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol. InChIKey: QOMBXPYXWGTFNR-PWAOTOFHSA-N.

Dane identyfikacyjne
Wzór sumarycznyC42H70O12
Masa molowa767.0 g/mol
Nazwa IUPAC(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
InChIKeyQOMBXPYXWGTFNR-PWAOTOFHSA-N
SMILESC[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2O[C@H]3C[C@@]4([C@H](C[C@H]([C@H]5[C@]4(CC[C@@H]5/C(=C/CC=C(C)C)/C)C)O)[C@@]6([C@@H]3C([C@H](CC6)O)(C)C)C)C)CO)O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (20E)-Ginsenoside F4, Ginsenoside Rg6 (incorr, 20(E)-ginsenoside F4, Ginsenoside F4 (20E), ginsenoside F4 USP/EP/BP, 20(22)E-ginsenoside F4, orb1684961, orb3139077, Delta20(22)-Ginsenoside Rg6
Izomery (ten sam wzór sumaryczny)
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2E)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C42H70O12
(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol C42H70O12